BELIPHARM
0884.446.592 · rovalta.com · 10/11/2026
BELIPHARM
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOBELIPHARM is a Private company with limited liability incorporated in 2006. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Leuven.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0884.446.592
- Incorporation
- 04/10/2006
- Legal form
- Private company with limited liability
- Registered office
- Herestraat 13
3000 Leuven · FlandreSee on map - Contributed capital
- 6 200,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 19 filingsTrend over 19 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 36,3 k € | +29.6% | 28 k € | -40.8% | 47,3 k € | +89.0% | 25 k € | +288% | 6,5 k € |
| EBITDA | 35,9 k € | +29.9% | 27,7 k € | -41.1% | 47 k € | +87.5% | 25 k € | +288% | 6,5 k € |
| Operating result | 35,6 k € | +30.3% | 27,3 k € | -41.1% | 46,4 k € | +88.0% | 24,7 k € | +328% | 5,8 k € |
| Net result | 22,9 k € | +2.9% | 22,2 k € | -50.6% | 45 k € | +109% | 21,6 k € | +581% | 3,2 k € |
| Balance sheet | |||||||||
| Equity | 35,9 k € | +176% | 13 k € | +240% | -9,3 k € | +82.9% | -54,3 k € | +28.4% | -75,9 k € |
| Total assets | 449,8 k € | +216% | 142,5 k € | -2.5% | 146,1 k € | +571% | 21,8 k € | -87.0% | 167,7 k € |
| Cash | 8 k € | +3.4% | 7,7 k € | +8.3% | 7,1 k € | -34.7% | 10,9 k € | +15.4% | 9,5 k € |
| Debts | 413,9 k € | +220% | 129,5 k € | -16.6% | 155,4 k € | +104% | 76,1 k € | -68.8% | 243,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Ivo QUINTENS | Andere functieDirector27/04/2015 → 2023 accountsendedManager27/04/2015 → 2019 accountsended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Thanh Thuy LE THI | Associate04/10/2006 → 2023 accounts | |
Thanh Thuy THI LE | Associate04/10/2006 → 2007 accounts | |
Thu Hoa NGO | Manager04/10/2006 → 2018 accounts | |
Viet Vu TRUONG | Associate04/10/2006 → 2023 accounts |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 09/06/2026 | 04/07/2025 | 28/05/2024 | 26/06/2023 | 22/06/2022 | 17/06/2021 |
| General meeting | 04/05/2026 | 05/05/2025 | 06/05/2024 | 02/05/2023 | 02/05/2022 | 03/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 19 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 04/05/2026 | 09/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 05/05/2025 | 04/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 06/05/2024 | 28/05/2024 | Dutch | |
| Micro model | 31/12/2022 | 02/05/2023 | 26/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 02/05/2022 | 22/06/2022 | Dutch | |
| Micro model | 31/12/2020 | 03/05/2021 | 17/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 04/05/2020 | 03/06/2020 | Dutch | |
| Micro model | 31/12/2018 | 06/05/2019 | 25/06/2019 | Dutch | |
| Micro model | 31/12/2017 | 07/05/2018 | 13/06/2018 | Dutch | |
| Micro model | 31/12/2016 | 02/05/2017 | 27/06/2017 | Dutch | |
| Abridged model | 31/12/2015 | 02/05/2016 | 02/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 04/05/2015 | 15/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 05/05/2014 | 30/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 28/02/2013 | 19/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 07/05/2012 | 01/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 02/05/2011 | 31/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 03/05/2010 | 30/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 04/05/2009 | 29/07/2009 | Dutch | |
| Abridged model | 31/12/2007 | 05/05/2008 | 26/07/2008 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Ivo QUINTENS | Andere functieDirector27/04/2015 → 2023 accountsendedManager27/04/2015 → 2019 accountsended |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Thanh Thuy LE THI | Associate04/10/2006 → 2023 accounts | |
Thanh Thuy THI LE | Associate04/10/2006 → 2007 accounts | |
Thu Hoa NGO | Manager04/10/2006 → 2018 accounts | |
Viet Vu TRUONG | Associate04/10/2006 → 2023 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Herestraat 13, 3000 LeuvenCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00145467 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| BELIPHARMCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00145467 |
Events
- 2025Annual accounts 202522,9 k €↑
- 2024Annual accounts 202422,2 k €↓
- 2023Annual accounts 202345 k €↑
- 2022Annual accounts 202221,6 k €↑
- 2021Annual accounts 20213,2 k €↓
- 2020Annual accounts 202014,9 k €↑
- 2019Annual accounts 20194,7 k €↓
- 2018Annual accounts 201813,5 k €↑
- 2017Annual accounts 20171,5 k €↑
- 2016Annual accounts 2016-35,5 k €↑
- 2015Annual accounts 2015-66,5 k €↓
- 2014Annual accounts 2014-120,5 €↓
- 2013Annual accounts 20137,2 k €↑
- 2012Annual accounts 2012-31,1 k €↓
- 2011Annual accounts 2011907,2 €↓
- 2010Annual accounts 201032,5 k €↑
- 2009Annual accounts 2009-12,5 k €↓
- 2008Annual accounts 20085,9 k €↑
- 2007Annual accounts 2007-20,7 k €
- 04/10/2006IncorporationPrivate company with limited liability